# Ernexa Therapeutics Inc.: filings

ERNA · Nasdaq · CIK 748592 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/erna.md) · [Financials](/companies/erna/financials.md) · [Filings](/companies/erna/filings.md) · [Insiders](/companies/erna/insiders.md)

## Reports and events: 421 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 366, 8-K 268, 3 58, 10-Q 53, SC 13D/A 35, SC 13G/A 28, CORRESP 20, 10-K 18, DEF 14A 18, EFFECT 18, UPLOAD 18, 424B3 17, DEFA14A 17, SC 13G 17, 4/A 16, SCHEDULE 13G/A 14, S-3 11, 425 10, D 10, PRE 14A 9, 424B5 8, S-8 8, SC 13D 7, 8-K/A 6, S-1 6, ARS 5, SCHEDULE 13D/A 4, SEC STAFF LETTER 4, 10-K/A 3, S-1/A 3, S-4/A 3, SCHEDULE 13G 3, 8-A12B 2, CERT 2, DEFR14A 2, S-3/A 2, 25 1, 3/A 1, 5 1, 8-A12B/A 1, DEF 14C 1, DRS 1, DRSLTR 1, NT 10-K 1, NT 10-Q 1, POS AM 1, PRE 14C 1, RW 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 17:25 ET | [8-K](/filings/0001493152-26-047287.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047287 |
| 2026-09-16 | 17:30 ET | [8-K](/filings/0001493152-26-042963.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042963 |
| 2026-09-16 | 16:50 ET | [8-K](/filings/0001493152-26-042934.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-042934 |
| 2026-08-06 | 17:31 ET | [10-Q](/filings/0001493152-26-036424.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036424 |
| 2026-07-02 | 16:40 ET | [8-K](/filings/0001493152-26-031930.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-031930 |
| 2026-07-02 | 16:30 ET | [8-K](/filings/0001493152-26-031920.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-031920 |
| 2026-06-26 | 16:30 ET | [8-K](/filings/0001493152-26-030306.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-030306 |
| 2026-05-11 | 17:09 ET | [DEF 14A](/filings/0001493152-26-022281.md) | Proxy statement, period 2026-05-11 | 0001493152-26-022281 |
| 2026-05-11 | 17:02 ET | [10-Q](/filings/0001493152-26-022276.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022276 |
| 2026-05-04 | 16:10 ET | [8-K](/filings/0001493152-26-021112.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-021112 |
| 2026-03-20 | 17:00 ET | [8-K](/filings/0001493152-26-011922.md) | 3.01 Delisting notice | 0001493152-26-011922 |
| 2026-03-13 | 17:22 ET | [10-K](/filings/0001493152-26-010102.md) | Annual report, period 2025-12-31 | 0001493152-26-010102 |
| 2026-02-26 | 16:31 ET | [8-K](/filings/0001493152-26-008182.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008182 |
| 2026-02-17 | 21:26 ET | [SCHEDULE 13D/A](/filings/0001104659-26-016685.md) | Ownership report, active investor, amended | 0001104659-26-016685 |
| 2026-02-11 | 17:10 ET | [8-K](/filings/0001493152-26-006227.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006227 |
| 2026-02-05 | 09:46 ET | [S-1/A](/filings/0001493152-26-005215.md) | Registration statement, amended | 0001493152-26-005215 |
| 2026-02-04 | 21:59 ET | [S-1/A](/filings/0001493152-26-004987.md) | Registration statement, amended | 0001493152-26-004987 |
| 2026-02-03 | 20:10 ET | [S-1](/filings/0001493152-26-004809.md) | Registration statement | 0001493152-26-004809 |
| 2025-12-11 | 08:31 ET | [8-K](/filings/0001493152-25-027167.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-027167 |
| 2025-11-07 | 16:30 ET | [10-Q](/filings/0001493152-25-021287.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021287 |
| 2025-08-13 | 16:31 ET | [10-Q](/filings/0001493152-25-011910.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011910 |
| 2025-07-07 | 16:39 ET | [8-K](/filings/0001641172-25-018009.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-018009 |
| 2025-06-12 | 16:37 ET | [8-K](/filings/0001641172-25-014877.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-014877 |
| 2025-06-11 | 20:39 ET | [SCHEDULE 13D/A](/filings/0001104659-25-058646.md) | Ownership report, active investor, amended | 0001104659-25-058646 |
| 2025-06-09 | 16:30 ET | [8-K](/filings/0001641172-25-014318.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001641172-25-014318 |
| 2025-06-02 | 16:30 ET | [8-K](/filings/0001641172-25-013249.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013249 |
| 2025-05-07 | 16:30 ET | [10-Q](/filings/0001641172-25-009044.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009044 |
| 2025-04-14 | 16:45 ET | [DEF 14A](/filings/0001641172-25-004585.md) | Proxy statement, period 2024-12-31 | 0001641172-25-004585 |
| 2025-04-04 | 10:55 ET | [SCHEDULE 13D/A](/filings/0001104659-25-032062.md) | Ownership report, active investor, amended | 0001104659-25-032062 |
| 2025-04-03 | 08:55 ET | [8-K](/filings/0001641172-25-002514.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001641172-25-002514 |
| 2025-03-26 | 07:30 ET | [8-K](/filings/0001641172-25-000681.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-000681 |
| 2025-03-24 | 16:30 ET | [8-K](/filings/0001641172-25-000300.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-000300 |
| 2025-03-12 | 16:20 ET | [10-K](/filings/0001493152-25-010051.md) | Annual report, period 2024-12-31 | 0001493152-25-010051 |
| 2025-03-12 | 16:15 ET | [8-K](/filings/0001493152-25-010049.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-010049 |
| 2025-03-05 | 17:55 ET | [SCHEDULE 13D/A](/filings/0001104659-25-020984.md) | Ownership report, active investor, amended | 0001104659-25-020984 |
| 2025-02-13 | 16:30 ET | [8-K](/filings/0001493152-25-006446.md) | 5.08 Item not in the standard list | 0001493152-25-006446 |
| 2025-01-10 | 16:15 ET | [8-K](/filings/0001493152-25-001704.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001493152-25-001704 |
| 2025-01-03 | 16:15 ET | [8-K](/filings/0001493152-25-000246.md) | 3.01 Delisting notice | 0001493152-25-000246 |
| 2024-11-12 | 17:16 ET | [10-Q](/filings/0001493152-24-044841.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044841 |
| 2024-11-05 | 16:30 ET | [S-1](/filings/0001493152-24-043663.md) | Registration statement | 0001493152-24-043663 |
| 2024-10-29 | 16:30 ET | [8-K](/filings/0001493152-24-042902.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-042902 |
| 2024-10-07 | 16:15 ET | [DEF 14A](/filings/0001493152-24-040286.md) | Proxy statement, period 2024-10-07 | 0001493152-24-040286 |
| 2024-09-27 | 16:15 ET | [8-K](/filings/0001493152-24-038532.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-038532 |
| 2024-09-25 | 16:36 ET | [8-K](/filings/0001493152-24-038129.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-038129 |
| 2024-09-23 | 16:30 ET | [8-K](/filings/0001493152-24-037815.md) | 3.01 Delisting notice | 0001493152-24-037815 |
| 2024-08-19 | 17:00 ET | [8-K](/filings/0001493152-24-033119.md) | 8.01 Other events | 0001493152-24-033119 |
| 2024-08-13 | 16:30 ET | [10-Q](/filings/0001493152-24-031639.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031639 |
| 2024-05-14 | 17:14 ET | [10-Q](/filings/0001140361-24-026010.md) | Quarterly report, period 2024-03-31 | 0001140361-24-026010 |
| 2024-03-22 | 16:30 ET | [8-K](/filings/0001140361-24-014809.md) | 3.01 Delisting notice | 0001140361-24-014809 |
| 2024-03-18 | 07:30 ET | [10-K/A](/filings/0001140361-24-013709.md) | Annual report, amended, period 2023-12-31 | 0001140361-24-013709 |

Page 1 of 9. [Older](/companies/erna/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 14:05 ET. No prices; not investment advice.